Allison Schwartz - 05 Sep 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Director
Signature
/s/ Allison Schwartz
Issuer symbol
BIO
Transactions as of
05 Sep 2025
Net transactions value
-$9,749
Form type
4
Filing time
09 Sep 2025, 16:21:57 UTC
Previous filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Allison Schwartz Director C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES /s/ Allison Schwartz 09 Sep 2025 0001924980

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +92 +6.6% $0.000000 1,489 06 Sep 2025 Direct F1
transaction BIO BIO.B Bio-Rad A Common Stock Tax liability $9,749 -33 -2.2% $295.43 1,456 06 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Award $0 +914 $0.000000 914 05 Sep 2025 Bio-Rad A Common Stock 914 $0.000000 Direct F2, F3
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -92 -25% $0.000000 277 06 Sep 2025 Bio-Rad A Common Stock 92 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.